SCHEMBL14413758

SCHEMBL14413758

O=C(Nc1ccc(C(F)(F)F)cc1)N1CCC(C(F)(F)F)CC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 5/20 0.62
▸ NAMPT P43490 3/20 0.59
▸ MAPT P10636 1/20 0.55
▸ EPHX2 P34913 3/20 0.54
▸ CNR1 P21554 1/20 0.54
▸ CNR2 P34972 1/20 0.54
▸ HPGDS O60760 1/20 0.54
▸ FAAH O00519 1/20 0.53
▸ PRKAB2 O43741 1/20 0.53
▸ PRKAG1 P54619 1/20 0.53
▸ PRKAA2 P54646 1/20 0.53
▸ PRKAA1 Q13131 1/20 0.53
▸ PRKAG3 Q9UGI9 1/20 0.53
▸ PRKAG2 Q9UGJ0 1/20 0.53
▸ PRKAB1 Q9Y478 1/20 0.53
▸ CCR2 P41597 1/20 0.53
▸ KCNH2 Q12809 1/20 0.53
▸ PAK1 Q13153 1/20 0.53
▸ NPY2R P49146 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32660750 0.86 TRPV1 (0.62) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL14393776 0.86 EPHX2 (0.70) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL4559682 0.83 MAPT (0.73) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL14306236 0.83 MAPT (0.69) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL23573367 0.82 EPHX2 (0.64) TRPV1EPHX2
SCHEMBL8244866 0.82 TRPV1 (0.62) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL4011037 0.82 EPHX2 (0.79) EPHX2
SCHEMBL6153200 0.82 KMT2A (0.69) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL20271463 0.80 TRPV1 (0.63) TRPV1NAMPTMAPTEPHX2CNR1
SCHEMBL15134839 0.79 EPHX2 (0.69) TRPV1NAMPTMAPTEPHX2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007106706-A1 CYCLIC UREA COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS EFFECTIVE FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-09-20 — — WO disclosed
Send feedback